INTENDED USE Giardia Ag Feces Rapid Test is a sandwich lateral flow immunochromatographic assay for the qualitative detection of Giardia antigen in feces. Assay Time: 5-10 min Sample: Feces 25PCS/BOX
INTENDED USE THE ONE STEP ANTI-DENGUE (IGM & IGG) TRI-LINE TEST IS A COLLOIDAL GOLD ENHANCED, RAPID IMMUNOCHROMATOGRAPHIC ASSAY FOR THE QUALITATIVE DETECTION OF ANTIBODIES (IGM & IGG) TO DENGUE VIRUS (DV) IN HUMAN WHOLE BLOOD, SERUM OR PLASMA. THIS TEST IS A SCREENING TEST, AND ALL POSITIVES MUST BE CONFIRMED USING AN ALTERNATE TEST SUCH AS WESTERN BLOT. THE TEST IS INTENDED FOR HEALTHCARE PROFESSIONAL USE ONLY. 25PCS/BOX
MOR Test SUMMARY AND EXPLANATION OF THE TEST The MOR Gold Rapid Screen Test Strip is a fast and easy to read membrane chromatographic immunoassay with no need for instrument. The method employs a unique combination of monoclonal and polyclonal antibodies to specifically identify Morphine in urine with a high degree of sensitivity. Morphine, one of opiates�¢?? derivatives, is central nervous system stimulants that produce alertness, wakefulness, increased energy, reduced hunger, and an overall feeling of well-being. Morphine has been the preferred drug for the management of pain in cases of advanced cancer and other severe conditions. Morphine and other Opiates�¢?? metabolites may be detected in urine as a result of heroin morphine, codeine, or poppy seed intake. Administration of large doses of Morphine can cause tolerance and physiological dependence in users, and can lead to substance abuse. D-Morphine is controlled substances. GC/MS or immunoassay method has been developed for the determination of 300ng/ml for Morphine. MOR Test PRINCIPLE During a test labeled antibody-dye conjugate mixes with urine specimen and binds to the free drug if it is presented in the sample, to form an antibody-antigen complex. This complex prevents the formation of pink color bands in the test zone of the dip-stick if drug to be detected in specimen is above the detection levels (300ng/ml for Morphine). In case of absent of drug and its metabolites, unbound dye conjugate will bind to the antigens immobilized in the test zone to form a pink reaction line. To serve as a quality control for the assay, another pink line will always appears in the test zone regardless positive or negative result. Packaging Details: Pouch+Box+Carton packaging (1) With our company's Logo (2) With the natural package (3) With OEM package (4) ODM
General Information Items : MOR/MET/THC/AMP/MDMA/MTD/COC/TCA/BAR/BZO, up to 15 kinds of Drug Tests Format: Strip, Cassette, Cup,and Panel Specimen: Urine Packaging Details: Pouch+Box+Carton packaging (1) With our companyâ??s Logo (2) With the natural package (3) With OEM package (4) ODM Anna Lee Int'l Market Executive SPANBIO T
Antibiotics Residue In Milk Rapid Test(Beta lactam & Tetracycline Rapid Test) INTENDED USE Beta lactam + Tetracycline Rapid Test is a competitive immunoassay for the semi-quantitative detection of the presence of Beta lactam and Tetracycline residue in milk. KIT COMPONENT 1.6 plastic canister each containing 8 microwells and 8 strips 2.48 pipettes 3.Product Manual Package:8 Strips/Bottle , 48 Strips/Box Packaging Details: Pouch+Box+Carton packaging (1) With our companyâ??s Logo (2) With the natural package (3) With OEM package (4) ODM Anna Lee Int'l Market Executive SPANBIO Tel: +86(755)89589611 Cell Phone:+8613417551798(WhatsApp) anna.lee@spanbio.com
HBsAg Rapid Test Cassette Uncut Sheet Specimen :WB/S/P Size :300*60mm One-Step HBsAg Rapid Test is to detect the Hepatitis B Virus Surface Antigen in serum, plasma or whole blood. Analytical sensitivity : 1ng/ml of HBsAg Sensitivity :100% , Specificity : 100% Specimen : Serum , Plasma or Whole Blood Reading Time : 10 min
Uncut Sheet HIV 1/2 Tri-Lines Rapid Test Package:30sheets/pouch Specimen:Whole blood/Serum/plasma INTENDED USE The HIV-1/2 Rapid Screen Test (RST) is a qualitative test for the detection of antibodies to Human Immunodeficiency Virus type 1 and 2(HIV-1/2) in human serum/plasma and whole blood. It is considered as an initial screening test for HIV-1/2 antibodies. All positive specimens must be confirmed with Western Blot or other qualified EIA. PRECAUTION 1.For in vitro diagnostic uses only. 2.All patient samples should be treated as if capable of transmitting diseases. 3.Do not use test kit beyond expiration date. 4.Icteric, lipemic, hemolysed, heat treated and contaminated sera may cause erroneous results. SUMMARY AND EXPLANATION OF THE TEST It has been shown that the acquired immunodeficiency syndrome (AIDS) is caused by viruses transmitted by sexual contact, transfusion, use of contaminated blood products and sharing contaminated needles. HIV-1 and HIV-2 viruses have been isolated from patients with AIDS and AIDS-related complex (ARC), high-risk persons for AIDS. HIV-1 and HIV-2 viruses delete T helper cells, a subpopulation of T cells for body defense, thus causing AIDS patients susceptible to opportunistic infections and developing malignant tumors. The incidence of specific antibodies to HIV-1/2 is high in AIDS, ARC and persons with high risk for AIDS. The HIV-1/2 Rapid Screen Test is designed to detect antibodies to HIV-1/2 in AIDS patients, ARC or high risk persons and identify any potential donors carrying these antibodies in serum specimens. PRINCIPLE HIV-1/2 RST is a chromatographic immunoassay (CIA) for the detection of antibodies to HIV-1/2 in human serum/plasma and whole blood. HIV-1/2 specific antigens are precoated onto membrane as a capture reagent on the test region. During the test, specimen is allowed to react with the colloidal gold particles, which have been labeled with HIV-1/2 specific antigens. Antibodies to HIV-1/2, if present, a red colored band will develop on the membrane in proportion to the amount of HIV-1/2 antibodies present in the specimen. Absence of this red colored band in the test region suggests a negative result. To serve as a procedural control, red colored band in the control region will always appear regardless the presence of antibodies to HIV-1/2.
INTENDED USE Canine Distemper Virus Ag Test is a sandwich lateral flow immunochromatographic assay for the qualitative detection of canine Distemper virus (CDV Ag) in dog's secretions or serum. Assay Time: 5-10 min Sample: secretions or serum PRINCIPLE Canine Distemper Virus Ag Test is based on sandwich lateral flow immunochromatographic assay. The test device has a testing window. The testing window has an invisible T (test) zone and C (control) zone. When sample is applied into the sample hole on the device, the liquid will laterally flow on the surface of the test strip. If there is enough Distemper antigen in the sample, a visible T band will appear. The C band should always appear after a sample is applied, indicating a valid result. By this means, the device can accurately indicate the presence of Canine Distemper antigen in the sample.
Product Name: Coronavirus (COVID-19) Antigen Rapid Test Cassette (Swab), COVID-19 Antigen Test Kit, SARS COV 2 Variant Test Kits Sample type Throat OR nasal swab Detection type Qualitative Method: Colloidal Gold Rapid Test Function: Diagnose Certificate: ISO9001/ ISO13485/CE Format: Strip, Cassette, Midstream Sensitivity: 96.23% Specificity: 99.11% Accuracy: 98.56% Reading time: 15 minutes Packaging Details: Pouch+Box+Carton packaging (1) With our company's Logo (2) With the natural package (3) With OEM package (4) ODM
Product Name: Coronavirus (COVID-19) Antigen Rapid Test Cassette (Swab), COVID-19 Antigen Test Kit, SARS COV 2 Variant Test Kits Sample type Throat OR nasal swab Detection type Qualitative Method: Colloidal Gold Rapid Test Function: Diagnose Certificate: ISO9001/ ISO13485/CE Format: Cassette Sensitivity: 96.23% Specificity: 99.11% Accuracy: 98.56% Reading time: 15 minutes Packaging Details: Pouch+Box+Carton packaging (1) With our company's Logo (2) With the natural package (3) With OEM package (4) ODM
USA Manufactured, highly accurate, rapid COVID-19 Antigen test. Clinically validated by third-party medical institutions in USA and Europe (Denmark, Poland). The test is highly specific and sensitive (Specificity 100%, Sensitivity 99.1%). Manufacturer has a decade of experience in rapid testing. Available in either bulk or home-use packaging. Manufcatured and ships out of Miami, Florida.
USA Manufactured, highly accurate, rapid COVID-19 & Flu (influenza A&B) rapid antigen test. Clinically validated on large patient cohorts. The test is highly specific and sensitive: COVID-19: Sensitivity 99.1%, Specificity 99.5% Influenza A: Sensitivity 93.1%, Specificity 98.41% Influenza B: Sensitivity 94.2%, Specificity 98.59% Florida. Manufacturer has a decade of experience in rapid testing. Has CE. Available in either bulk or home-use packaging. Manufactured and ships out of Miami, Florida.
USA Manufactured, highly accurate, rapid COVID-19 Antibody test. Clinically validated in the USA by Harvard and UCSF Universities, and found to be best-in-class of Antibody tests. 95-100% accuracy in identifying patients after days 12. Manufacturer has a decade of experience in rapid testing. Available in either bulk or home-use packaging. Manufcatured and ships out of Miami, Florida.
Health Canada Authorised Rapid Test The COVID-19 antigen rapid test device is a lateral flow in-vitro immunoassay intended to be used for the qualitative detection of the SARS-CoV-2 viral nucleoprotein. This device will detect both viable and nonviable virus in both nasopharyngeal and oropharyngeal secretions. This test had been authorized for point of care use by Health Canada and is available for immediate dispatch MediGuard Systems of Canada is an Authorised distributor of the Assuretech Rapid Antigen test. Support documentation and details available on request
Introducing our Rapid Malaria Testing Kit, a breakthrough in diagnosing malaria with speed and accuracy. This cutting-edge kit is designed for easy and quick detection of the malaria parasite, revolutionizing the way healthcare professionals identify this life-threatening disease. With a user-friendly approach, it requires only a small blood sample to deliver results within minutes, enabling swift and informed medical decisions. Our kit boasts high sensitivity and specificity, ensuring reliable diagnoses even in low-infection scenarios. Its compact design and portability make it ideal for remote and resource-limited settings. Trust our Rapid Malaria Testing Kit for fast, dependable, and life-saving malaria diagnosis, providing critical support in the fight against this global health challenge.
Our Rapid Typhoid Testing Kit is a cutting-edge solution for swift and accurate diagnosis of typhoid fever. This advanced kit is designed for quick detection of the Salmonella Typhi bacteria, streamlining the diagnostic process for healthcare professionals. With a user-friendly approach, it requires a small blood sample and delivers results within minutes, enabling rapid treatment decisions. The kit exhibits exceptional sensitivity and specificity, ensuring reliable diagnoses even in low-infection scenarios. Its compact, portable design makes it ideal for remote and resource-limited areas. Trust our Rapid Typhoid Testing Kit for fast, dependable, and life-saving typhoid fever diagnosis, enhancing patient care and containment of this infectious disease.
According to European standards and FDA EUA lowFlex och Boson
1 million flo flex test kits available LA OTG
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus. EUA and CE pass shelf life: 24months since manufacturing date packing:2pcs/box,4pcs/box and so on It is for self testing and OTC, for home use, school , and any group .
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus. View File Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
